1.
Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society.
Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.
Primary immune thrombocytopenia in adults. Guidelines for diagnosis and treatment anno 2013 proposed by the Belgian Hematological Society